Sign up to save your podcasts
Or
Share Michelle Carnahan, Thirty Madison, on a human-first approach to healthcare
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Michelle Carnahan, Thirty Madison, on a human-first approach to healthcare
In this episode, we interview Michelle Carnahan, President of Thirty Madison. We discuss Michelle’s pivot from pharmaceutical executive to leader of a health tech unicorn and what that means for Thirty Madison going forward.
Thirty Madison’s mission is to be a human-first healthcare company delivering specialized care and treatment to everyone. They recently completed a $140M Series C raise led by HealthQuest Capital. They join Maveron and Polaris Partners as lead investors in Thirty Madison.
View all episodes
By The Pulse by Wharton Digital HealthIn this episode, we interview Michelle Carnahan, President of Thirty Madison. We discuss Michelle’s pivot from pharmaceutical executive to leader of a health tech unicorn and what that means for Thirty Madison going forward.
Thirty Madison’s mission is to be a human-first healthcare company delivering specialized care and treatment to everyone. They recently completed a $140M Series C raise led by HealthQuest Capital. They join Maveron and Polaris Partners as lead investors in Thirty Madison.